注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Pear Therapeutics Inc(原名:Thimble Point Acquisition Corp)是一家商業階段的醫療保健公司。該公司致力於開發一類新的基於軟件的藥物,稱為處方數字療法(PDT),它使用軟件來治療疾病。該公司的產品包括重置產品、reSET-O和Somryst。該公司的重置產品適用於作為單一療法治療物質使用障礙(SUD)。reSET-O產品開髮用於與丁丙諾啡聯合治療阿片類藥物使用障礙(OUD)。Somryst產品是唯一基於軟件和指南推薦的慢性失眠治療方法。該公司的產品線包括14個候選產品,包括精神病學、神經病學和中樞神經系統治療領域以外的候選產品,如胃腸(GI)、腫瘤學和心血管。該公司專注於精神疾病和神經系統疾病,這支持其將自己的產品商業化的戰略。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Elon S. Boms | 40 | - | CEO & Chairman of the Board |
Steven J. Benson | 62 | - | COO & Director |
Henry S. Miller | 75 | 2021 | Independent Director |
Michael J. Christenson | 62 | 2021 | Independent Director |
Meghan M. FitzGerald | 50 | 2021 | Independent Director |
Corey M. McCann | 43 | 2013 | Founder & Director |
Alex Paul Pentland | 72 | - | Member of Scientific Advisory Board |
Harold S. Koplewicz | 71 | - | Member of Scientific Advisory Board |
Magali Haas | - | - | Member of Scientific Advisory Board |
Eric C. Leuthardt | - | - | Member of Scientific Advisory Board |
Walter Greenleaf | - | - | Member of Scientific Advisory Board |
Joann Difede | - | - | Member of Scientific Advisory Board |
Patrick J. Kennedy | - | - | Member of Scientific Advisory Board |
Paul Summergrad | - | - | Member of Scientific Advisory Board |
Albert A. Rizzo | - | - | Member of Scientific Advisory Board |
Jeffrey A. Lieberman | - | - | Member of Scientific Advisory Board |
Lisa A. Marsch | - | - | Member of Scientific Advisory Board |
Alison Perry Bauerlein | 43 | 2021 | Independent Director |
Shivakumar Rajaraman | 50 | 2022 | Independent Director |
Paul Mango | - | 2022 | Independent Director |
Timothy A. Wicks | 58 | 2022 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核